PL207570A1 - Sposob wytwarzania nowych pochodnych 3-(1-pirazolilo)-pirydazyny - Google Patents

Sposob wytwarzania nowych pochodnych 3-(1-pirazolilo)-pirydazyny

Info

Publication number
PL207570A1
PL207570A1 PL20757078A PL20757078A PL207570A1 PL 207570 A1 PL207570 A1 PL 207570A1 PL 20757078 A PL20757078 A PL 20757078A PL 20757078 A PL20757078 A PL 20757078A PL 207570 A1 PL207570 A1 PL 207570A1
Authority
PL
Poland
Prior art keywords
pirazolyl
pyridazine
new derivatives
making new
making
Prior art date
Application number
PL20757078A
Other languages
English (en)
Other versions
PL111252B1 (en
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of PL207570A1 publication Critical patent/PL207570A1/pl
Publication of PL111252B1 publication Critical patent/PL111252B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1978207570A 1977-06-13 1978-06-12 Process for preparing novel derivatives of 3-/1-pyrazolylo/-pyridazine PL111252B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77GO1373A HU175471B (hu) 1977-06-13 1977-06-13 Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina

Publications (2)

Publication Number Publication Date
PL207570A1 true PL207570A1 (pl) 1979-05-21
PL111252B1 PL111252B1 (en) 1980-08-30

Family

ID=10996834

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978207570A PL111252B1 (en) 1977-06-13 1978-06-12 Process for preparing novel derivatives of 3-/1-pyrazolylo/-pyridazine

Country Status (25)

Country Link
US (1) US4251658A (pl)
JP (1) JPS5416487A (pl)
AT (1) AT357548B (pl)
AU (1) AU521394B2 (pl)
BE (1) BE867967A (pl)
BG (1) BG28709A3 (pl)
CA (1) CA1095912A (pl)
CH (1) CH638202A5 (pl)
CS (1) CS204029B2 (pl)
DD (1) DD140043A5 (pl)
DE (1) DE2825906A1 (pl)
DK (1) DK263078A (pl)
ES (1) ES470750A1 (pl)
FI (1) FI64156C (pl)
FR (1) FR2394542A1 (pl)
GB (1) GB1603958A (pl)
HU (1) HU175471B (pl)
IL (1) IL54816A (pl)
IT (1) IT1098216B (pl)
NL (1) NL7806380A (pl)
NO (1) NO149210C (pl)
PL (1) PL111252B1 (pl)
SE (1) SE437517B (pl)
SU (2) SU797577A3 (pl)
YU (1) YU140078A (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176100B (en) * 1977-10-25 1980-12-28 Gyogyszerkutato Intezet Process for preparing new 3-/1-pyrazolyl/-pyridazine derivatives
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4353905A (en) * 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
US4590194A (en) * 1981-10-05 1986-05-20 Sterling Drug Inc. 3-[methyl or dimethyl)amino]-6-(pyridinyl)pyridazines and their cardiotonic use
US4503056A (en) * 1982-03-02 1985-03-05 Abbott Laboratories 1-(Pyridazinyl)pyrazoline derivatives
DE3825867A1 (de) * 1988-03-04 1989-09-14 Bayer Ag Heterocyclisch substituierte sulfonylaminoazole und ihre verwendung als herbizide
US5536701A (en) * 1994-10-11 1996-07-16 Monsanto Company 3-pyrazolyloxypyridazines, herbicidal compositions and uses thereof
EP1565150A1 (fr) * 2002-11-20 2005-08-24 L'oreal Utilisation d'un compose pyrazolcarboxamide pour stimuler la pousse des fibres keratiniques et/ou freiner leur chute
FR2847160A1 (fr) * 2002-11-20 2004-05-21 Oreal Composition capillaire contenant un compose pyrasol-carboxamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
EP2386554A1 (en) * 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Compounds active at the histamine H3 receptor
JP2009537596A (ja) * 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用
EP2079732B9 (en) * 2006-05-29 2012-03-21 High Point Pharmaceuticals, LLC 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
EP2014656A3 (en) * 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
AR081626A1 (es) * 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595920B2 (de) * 1964-11-04 1978-08-10 Merck Patent Gmbh, 6100 Darmstadt 4-(co-Piperazinoalkyl)-pyrazole, ihre Salze und Verfahren zu ihrer Herstellung
JPS5831347B2 (ja) * 1975-09-05 1983-07-05 中外製薬株式会社 ピラゾリルピリダジンユウドウタイノ セイホウ

Also Published As

Publication number Publication date
ATA414478A (de) 1979-12-15
CA1095912A (en) 1981-02-17
FI781856A7 (fi) 1978-12-14
ES470750A1 (es) 1979-01-16
FI64156C (fi) 1983-10-10
SU797577A3 (ru) 1981-01-15
US4251658A (en) 1981-02-17
NO149210B (no) 1983-11-28
IL54816A0 (en) 1978-07-31
FR2394542A1 (fr) 1979-01-12
HU175471B (hu) 1980-08-28
FR2394542B1 (pl) 1980-12-05
NO782043L (no) 1978-12-14
NL7806380A (nl) 1978-12-15
PL111252B1 (en) 1980-08-30
SE7806576L (sv) 1978-12-14
IT1098216B (it) 1985-09-07
AU521394B2 (en) 1982-04-01
SE437517B (sv) 1985-03-04
JPS5416487A (en) 1979-02-07
AU3683678A (en) 1979-12-06
CH638202A5 (de) 1983-09-15
DK263078A (da) 1978-12-14
DE2825906A1 (de) 1979-01-18
AT357548B (de) 1980-07-10
IL54816A (en) 1981-09-13
SU860703A1 (ru) 1981-08-30
BE867967A (fr) 1978-12-11
FI64156B (fi) 1983-06-30
GB1603958A (en) 1981-12-02
NO149210C (no) 1984-03-07
BG28709A3 (bg) 1980-06-16
IT7824490A0 (it) 1978-06-13
CS204029B2 (en) 1981-03-31
DD140043A5 (de) 1980-02-06
YU140078A (en) 1983-01-21
JPS569506B2 (pl) 1981-03-02

Similar Documents

Publication Publication Date Title
PL204549A1 (pl) Sposob wytwarzania pochodnych pirolidyny
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL204550A1 (pl) Sposob wytwarzania pochodnych pirolidyny
FI781856A7 (fi) Foerfarande foer framstaellning av 3-(1-piperazolyl)-pyridazin-derivat
PL207192A1 (pl) Sposob wytwarzania nowych pochodnych 5,11-dwuhydro-6h-pirydo/2,3-b/benzodwuazepinonow-6
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL208757A1 (pl) Sposob wytwarzania pochodnych izochinoliny
PL190247A1 (pl) Sposob wytwarzania nowych podstawionych heterocyklicznych n-alkanoloamin
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL204041A1 (pl) Sposob wytwarzania nowych pochodnych 4"-aminooleandomycyny
PL205135A1 (pl) Sposob wytwarzania pochodnych 3-(tiometylo)-cefalosporyn
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL204672A1 (pl) Sposob wytwarzania nowych pochodnych azetydynonu
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL209049A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL205745A1 (pl) Sposob wytwarzania nowych pochodnych 1/3-(3,4,5-trojmetoksyfenoksy)-2-hydroksypropylo/-4-arylopiperazyny
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2